Reduce Tobacco Use in People Living With HIV in Switzerland: A Pragmatic Randomized Trial Within the Swiss HIV Cohort Study

Status: Recruiting
Location: See all (7) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this trial is to test the effectiveness of offering a menu of different tobacco smoking substitutional products (e-cigarettes, nicotine pouches, nicotine patches in addition to usual of care) for smokers in the SHCS (Swiss HIV Cohort Study) in achieving self-reported 7-day tobacco cigarette abstinence at 6 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Signed informed consent for the data collection and participation in the SHCS (Cohort consent).

• Signed informed consent to be randomized to future interventions (Randomization consent).

• Age 18 years or older.

• Smoked one or more tobacco cigarettes per day (smoking status = yes) at the time of enrolment.

Locations
Other Locations
Switzerland
Cantonal Hospital Aarau
NOT_YET_RECRUITING
Aarau
University Hospital Basel
RECRUITING
Basel
Inselspital Bern
RECRUITING
Bern
University Hospital Geneva
RECRUITING
Geneva
University Hospital Lausanne
RECRUITING
Lausanne
Cantonal Hospital St. Gallen
RECRUITING
Sankt Gallen
University Hospital Zurich
RECRUITING
Zurich
Contact Information
Primary
Matthias Briel, Prof.
Mathias.briel@usb.ch
+ 4161 265 3815
Backup
Christof Schönenberger, Dr.
ChristofManuel.Schoenenberger@usb.ch
Time Frame
Start Date: 2025-02-20
Estimated Completion Date: 2027-12
Participants
Target number of participants: 972
Treatments
Experimental: Smoking substitution menu
Offer of preference-based smoking substitution menu, consisting of e-cigarettes or nicotine pouches or nicotine patches in addition to standard of care.
No_intervention: Standard of care group
Standard smoking cessation counselling according to routine care in the SHCS.
Related Therapeutic Areas
Sponsors
Collaborators: Novartis Foundation for Medical-Biological Research, Swiss National Science Foundation
Leads: University Hospital, Basel, Switzerland

This content was sourced from clinicaltrials.gov